173 related articles for article (PubMed ID: 14523551)
1. Immunology and functional genomics of Behçet's disease.
Zierhut M; Mizuki N; Ohno S; Inoko H; Gül A; Onoé K; Isogai E
Cell Mol Life Sci; 2003 Sep; 60(9):1903-22. PubMed ID: 14523551
[TBL] [Abstract][Full Text] [Related]
2. T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behçet's disease.
Pervin K; Childerstone A; Shinnick T; Mizushima Y; van der Zee R; Hasan A; Vaughan R; Lehner T
J Immunol; 1993 Aug; 151(4):2273-82. PubMed ID: 7688396
[TBL] [Abstract][Full Text] [Related]
3. Association of HLA-B51 subtypes and Behçet's disease in Spain.
González-Escribano MF; Rodríguez MR; Walter K; Sanchez-Roman J; García-Lozano JR; Núñez-Roldán A
Tissue Antigens; 1998 Jul; 52(1):78-80. PubMed ID: 9714478
[TBL] [Abstract][Full Text] [Related]
4. Behçet's disease: an update on the pathogenesis.
Gül A
Clin Exp Rheumatol; 2001; 19(5 Suppl 24):S6-12. PubMed ID: 11760403
[TBL] [Abstract][Full Text] [Related]
5. Role of gamma delta T cells in pathogenesis and diagnosis of Behcet's disease.
Hasan A; Fortune F; Wilson A; Warr K; Shinnick T; Mizushima Y; van der Zee R; Stanford MR; Sanderson J; Lehner T
Lancet; 1996 Mar; 347(9004):789-94. PubMed ID: 8622334
[TBL] [Abstract][Full Text] [Related]
6. HLA-B51 gene and its expression in association with Behçet's Disease in Denizli Province of Turkey.
Atalay A; Yildiz-Demirtepe S; Tatlipinar S; Sanli-Erdoğan B; Cobankara V; Yildirim C; Bağci H; Atalay EO
Mol Biol Rep; 2008 Sep; 35(3):345-9. PubMed ID: 17594535
[TBL] [Abstract][Full Text] [Related]
7. Behçet's disease (Adamantiades-Behçet's disease).
Kaneko F; Togashi A; Saito S; Sakuma H; Oyama N; Nakamura K; Yokota K; Oguma K
Clin Dev Immunol; 2011; 2011():681956. PubMed ID: 21052488
[TBL] [Abstract][Full Text] [Related]
8. Preferential activation of circulating CD8+ and gammadelta T cells in patients with active Behçet's disease and HLA-B51.
Yasuoka H; Yamaguchi Y; Mizuki N; Nishida T; Kawakami Y; Kuwana M
Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S59-63. PubMed ID: 19026117
[TBL] [Abstract][Full Text] [Related]
9. HLA-B*5101 in Greek patients with Behçet's disease.
Koumantaki Y; Stavropoulos C; Spyropoulou M; Messini H; Papademetropoulos M; Giziaki E; Marcomichelakis N; Palimeris G; Kaklamanis P; Kaklamani E
Hum Immunol; 1998 Apr; 59(4):250-5. PubMed ID: 9568801
[TBL] [Abstract][Full Text] [Related]
10. The Behçet's disease-associated variant of the aminopeptidase ERAP1 shapes a low-affinity HLA-B*51 peptidome by differential subpeptidome processing.
Guasp P; Barnea E; González-Escribano MF; Jiménez-Reinoso A; Regueiro JR; Admon A; López de Castro JA
J Biol Chem; 2017 Jun; 292(23):9680-9689. PubMed ID: 28446606
[TBL] [Abstract][Full Text] [Related]
11. New perspective on Behçet's disease.
Sakane T
Int Rev Immunol; 1997; 14(1):89-96. PubMed ID: 9203029
[TBL] [Abstract][Full Text] [Related]
12. Associations of major histocompatibility complex class I chain-related molecule polymorphisms with Behcet's disease in Caucasian patients.
Hughes EH; Collins RW; Kondeatis E; Wallace GR; Graham EM; Vaughan RW; Stanford MR
Tissue Antigens; 2005 Sep; 66(3):195-9. PubMed ID: 16101830
[TBL] [Abstract][Full Text] [Related]
13. Sequencing-based typing of HLA-B*51 alleles and the significant association of HLA-B*5101 and -B*5108 with Behçet's disease in Greek patients.
Mizuki N; Ota M; Katsuyama Y; Yabuki K; Ando H; Shiina T; Palimeris GD; Kaklamani E; Ito D; Ohno S; Inoko H
Tissue Antigens; 2002 Feb; 59(2):118-21. PubMed ID: 12028538
[TBL] [Abstract][Full Text] [Related]
14. Behçet's disease: An immunogenetic perspective.
Salmaninejad A; Zamani MR; Shabgah AG; Hosseini S; Mollaei F; Hosseini N; Sahebkar A
J Cell Physiol; 2019 Jun; 234(6):8055-8074. PubMed ID: 30341905
[TBL] [Abstract][Full Text] [Related]
15. Streptococcal-related antigens stimulate production of IL6 and interferon-gamma by T cells from patients with Behcet's disease.
Hirohata S; Oka H; Mizushima Y
Cell Immunol; 1992 Apr; 140(2):410-9. PubMed ID: 1544169
[TBL] [Abstract][Full Text] [Related]
16. Behçet's disease associated with one of the HLA-B51 subantigens, HLA-B* 5101.
Mizuki N; Inoko H; Ando H; Nakamura S; Kashiwase K; Akaza T; Fujino Y; Masuda K; Takiguchi M; Ohno S
Am J Ophthalmol; 1993 Oct; 116(4):406-9. PubMed ID: 8213969
[TBL] [Abstract][Full Text] [Related]
17. Influence of human recombinant interferon-alpha2a (rhIFN-alpha2a) on altered lymphocyte subpopulations and monocytes in Behcet's disease.
Treusch M; Vonthein R; Baur M; Günaydin I; Koch S; Stübiger N; Eckstein AK; Peter HH; Ness T; Zierhut M; Kötter I
Rheumatology (Oxford); 2004 Oct; 43(10):1275-82. PubMed ID: 15252211
[TBL] [Abstract][Full Text] [Related]
18. HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies.
de Menthon M; Lavalley MP; Maldini C; Guillevin L; Mahr A
Arthritis Rheum; 2009 Oct; 61(10):1287-96. PubMed ID: 19790126
[TBL] [Abstract][Full Text] [Related]
19. Anti-MHC autoimmunity in Behçet's disease: T cell responses to an HLA-B-derived peptide cross-reactive with retinal-S antigen in patients with uveitis.
Kurhan-Yavuz S; Direskeneli H; Bozkurt N; Ozyazgan Y; Bavbek T; Kazokoglu H; Eksioglu-Demiralp E; Wildner G; Diedrichs-Möhring M; Akoglu T
Clin Exp Immunol; 2000 Apr; 120(1):162-6. PubMed ID: 10759778
[TBL] [Abstract][Full Text] [Related]
20. Is Behçet's disease a 'class 1-opathy'? The role of HLA-B*51 in the pathogenesis of Behçet's disease.
Giza M; Koftori D; Chen L; Bowness P
Clin Exp Immunol; 2018 Jan; 191(1):11-18. PubMed ID: 28898393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
